Cargando…

Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway

Detalles Bibliográficos
Autores principales: Ding, Xiaoyan, Sun, Wei, Chen, Jinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936145/
https://www.ncbi.nlm.nih.gov/pubmed/31892857
http://dx.doi.org/10.1186/s12935-019-1083-8
_version_ 1783483692675497984
author Ding, Xiaoyan
Sun, Wei
Chen, Jinglong
author_facet Ding, Xiaoyan
Sun, Wei
Chen, Jinglong
author_sort Ding, Xiaoyan
collection PubMed
description
format Online
Article
Text
id pubmed-6936145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69361452019-12-31 Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway Ding, Xiaoyan Sun, Wei Chen, Jinglong Cancer Cell Int Retraction Note BioMed Central 2019-12-30 /pmc/articles/PMC6936145/ /pubmed/31892857 http://dx.doi.org/10.1186/s12935-019-1083-8 Text en © The Author(s) 2019 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Ding, Xiaoyan
Sun, Wei
Chen, Jinglong
Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_full Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_fullStr Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_full_unstemmed Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_short Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
title_sort retraction note to: il‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the jnk/taz pathway
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936145/
https://www.ncbi.nlm.nih.gov/pubmed/31892857
http://dx.doi.org/10.1186/s12935-019-1083-8
work_keys_str_mv AT dingxiaoyan retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway
AT sunwei retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway
AT chenjinglong retractionnotetoil2augmentsthesorafenibinducedapoptosisinlivercancerbypromotingmitochondrialfissionandactivatingthejnktazpathway